Your browser doesn't support javascript.
loading
Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe.
Romio, Silvana; Weibel, Daniel; Dieleman, Jeanne P; Olberg, Henning K; de Vries, Corinne S; Sammon, Cormac; Andrews, Nick; Svanström, Henrik; Mølgaard-Nielsen, Ditte; Hviid, Anders; Lapeyre-Mestre, Maryse; Sommet, Agnès; Saussier, Christel; Castot, Anne; Heijbel, Harald; Arnheim-Dahlström, Lisen; Sparen, Par; Mosseveld, Mees; Schuemie, Martijn; van der Maas, Nicoline; Jacobs, Bart C; Leino, Tuija; Kilpi, Terhi; Storsaeter, Jann; Johansen, Kari; Kramarz, Piotr; Bonhoeffer, Jan; Sturkenboom, Miriam C J M.
Afiliação
  • Romio S; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Weibel D; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands ; Brighton Collaboration Foundation, Basel, Switzerland.
  • Dieleman JP; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Olberg HK; Department of Neurology, Haukeland University Hospital, Bergen, Norway.
  • de Vries CS; Department of Pharmacy & Pharmacology, University of Bath, Bath, United Kingdom.
  • Sammon C; Department of Pharmacy & Pharmacology, University of Bath, Bath, United Kingdom.
  • Andrews N; Health Protection Agency, London, United Kingdom.
  • Svanström H; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
  • Mølgaard-Nielsen D; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
  • Hviid A; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
  • Lapeyre-Mestre M; Department of Clinical Pharmacology, Toulouse University Hospital and Institut national de la santé et de la recherche médicale, Toulouse, France.
  • Sommet A; Department of Clinical Pharmacology, Toulouse University Hospital and Institut national de la santé et de la recherche médicale, Toulouse, France.
  • Saussier C; French National Agency for Medicines and Health Products Safety, Saint Denis, France.
  • Castot A; Medical Doctor - Consultant, Paris, France.
  • Heijbel H; Department of Vaccinology, Swedish Institute for Infectious Disease Control, Solna, Sweden.
  • Arnheim-Dahlström L; Department Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
  • Sparen P; Department Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
  • Mosseveld M; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Schuemie M; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van der Maas N; National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
  • Jacobs BC; Departments of Neurology and Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Leino T; Department of Vaccination and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland.
  • Kilpi T; Department of Vaccination and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland.
  • Storsaeter J; Department of Vaccines, Norwegian Institute of Public Health, Oslo, Norway.
  • Johansen K; Surveillance and Response Support Unit, European Centre for Disease Prevention and Control, ECDC, Stockholm, Sweden.
  • Kramarz P; Surveillance and Response Support Unit, European Centre for Disease Prevention and Control, ECDC, Stockholm, Sweden.
  • Bonhoeffer J; Brighton Collaboration Foundation, Basel, Switzerland ; Department of Infectious Diseases and Vaccinology, University Children's Hospital, Basel, Switzerland.
  • Sturkenboom MC; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.
PLoS One ; 9(1): e82222, 2014.
Article em En | MEDLINE | ID: mdl-24404128
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Síndrome de Guillain-Barré / Influenza Humana / Vírus da Influenza A Subtipo H1N1 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Síndrome de Guillain-Barré / Influenza Humana / Vírus da Influenza A Subtipo H1N1 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2014 Tipo de documento: Article